Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1800 studies found for:    "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
1 Suspended Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
2 Terminated
Has Results
Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin
3 Not yet recruiting A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms;   Adenocarcinoma
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: Ascorbic Acid
4 Terminated Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Intervention: Drug: Gemcitabine with escalating ascorbic acid
5 Terminated Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Interventions: Drug: Bardoxolone methyl;   Drug: Gemcitabine;   Drug: Placebo
6 Completed Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms
Interventions: Drug: Modified FOLFIRINOX;   Radiation: Stereotactic Body Radiotherapy (SBRT)
7 Recruiting Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer;   Cancer of Pancreas
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Radiation: Sterostatic body radiation Cohort A1: 1 dose therapy (SBRT)
8 Recruiting Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Conditions: Pancreas Cancer;   Localized Pancreas Cancer;   Non-metastatic Pancreas Cancer
Intervention: Drug: FOLFIRINOX Regimen
9 Completed Trial of Curcumin in Advanced Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Adenocarcinoma
Intervention: Drug: Curcumin
10 Completed Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: hMN14 (labetuzumab)
11 Suspended Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Dietary Supplement: Ketogenic diet
12 Recruiting Institut Paoli-Calmettes Pancreatic Neoplasms Database
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
13 Completed Acupuncture For Pancreatic Cancer Pain
Conditions: Pancreatic Neoplasms;   Pain
Intervention: Procedure: Acupuncture
14 Recruiting Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Condition: Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine;   Drug: Chemoradiation;   Drug: Capecitabine;   Procedure: Surgery
15 Recruiting Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Conditions: Stage ⅠA Pancreatic Cancer;   Stage ⅠB Pancreatic Cancer;   Stage ⅡA Pancreatic Cancer;   Stage ⅡB Pancreatic Cancer
Interventions: Drug: nab-paclitaxel;   Drug: gemcitabine;   Drug: oxaliplatin;   Drug: folinic acid;   Drug: fluorouracil
16 Terminated Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
Condition: Pancreatic Neoplasms
Intervention:
17 Recruiting Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer;   Cachexia;   Weight Loss
Intervention: Other: Tube feeding
18 Completed Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine with R115777;   Drug: Gemcitabine with Placebo
19 Active, not recruiting Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node;   Lymphadenopathy
Interventions: Procedure: EUS-FNA;   Device: nCLE
20 Unknown  Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies
Condition: Pancreatic Neoplasms
Intervention: Drug: Aroplatin (Liposomal NDDP, L-NDDP)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years